Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome.
Rees
J H
JH
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D010951:Plasma Exchange / Q000379:methods*; D011129:Polyradiculoneuropathy / Q000628:therapy*; D012008:Recurrence; D012307:Risk Factors; D012720:Severity of Illness Index
D000276:Adjuvants, Immunologic; D016756:Immunoglobulins, Intravenous